.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,780,038

« Back to Dashboard
Patent 7,780,038 protects QNASL and is included in one NDA.

This patent has seven patent family members in six countries.

Summary for Patent: 7,780,038

Title:Dispensing apparatus with dosage counter
Abstract: A dispensing apparatus (1) comprising a housing containing a dosage counter comprising at least two annular members (11, 13) and a cog (12), each being mounted rotationally. The housing is suitable for receiving, in use, a container (1) containing a product for dispensation. Each actuation of the apparatus causes the first annular member to incrementally rotate which, after a predetermined number of actuations of the apparatus, causes the cog to rotate, the rotation of the cog causing the second annular member to incrementally rotate.
Inventor(s): Ingram; Simon (Northampton, GB), Campling; Nick (Cambridgeshire, GB), Bradley; Duncan (Cambridgeshire, GB)
Assignee: Consort Medical plc (Hertfordshire, GB)
Application Number:11/597,354
Patent Claim Types:
see list of patent claims
Device;
Patent Metrics:
Source: PatentQuant.com
Field: Handling
Back Citations: 18th percentile
Forward Citations: 6th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-002Dec 17, 2014RXNo7,780,038► subscribeY
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-001Mar 23, 2012RXYes7,780,038► subscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,780,038

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0411384.1May 21, 2004
PCT Information
PCT FiledMay 23, 2005PCT Application Number:PCT/GB2005/002007
PCT Publication Date:December 01, 2005PCT Publication Number: WO2005/113044

International Patent Family for Patent: 7,780,038

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom2414187► subscribe
United Kingdom0411384► subscribe
Spain2339574► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc